Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
Clinical role
Automated PA chest-radiograph quality control, heart and thoracic-cavity diameter annotation, CTR measurement, structured reporting, and non-predictive longitudinal CTR tracking for clinician review.
Images and patients
X-ray/Radiography · Heart and thoracic cavity for cardiothoracic-ratio measurement
Key limitation
Keep in mind: The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Heart and thoracic cavity for cardiothoracic-ratio measurement Input: DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.
Who uses it?Intended users: Physicians or other licensed practitioners in healthcare institutions such as clinics, hospitals, healthcare facilities, residential care facilities, and long-term care services
What does the software produce?Output: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
What is its most important limitation?Key limitation: The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.
Clinical takeaway. Clinical role: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
Evidence takeaway. Evidence from the reviewed source record: FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.
A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
Physicians or other licensed practitioners in healthcare institutions such as clinics, hospitals, healthcare facilities, residential care facilities, and long-term care services
The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.
FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K212624
Samplen=840
IndependenceIndependence not established
K212624
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K212624. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The packet describes a software device installed on a computer with specific system requirements, DICOM chest X-ray input, and DICOM/JSON or DICOM Secondary Capture report output; its comparison table lists Ubuntu 18.04 and a Chrome 88.0.4324.182-or-later browser context. A specific PACS, RIS, EHR, interface version, and current commercial deployment topology are not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes iCTR as a software medical device designed to be installed on a computer with specific system requirements, operating on off-the-shelf hardware. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The iCTR is a non-invasive software medical device designed to be installed on the computer with specific system requirements." … "Software device that operates on off-the-shelf Yes Yes Same hardware". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes iCTR as a software medical device designed to be installed on a computer with specific system requirements, operating on off-the-shelf hardware. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The iCTR is a non-invasive software medical device designed to be installed on the computer with specific system requirements." … "Software device that operates on off-the-shelf Yes Yes Same hardware". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The packet describes a software device installed on a computer with specific system requirements, DICOM chest X-ray input, and DICOM/JSON or DICOM Secondary Capture report output; its comparison table lists Ubuntu 18.04 and a Chrome 88.0.4324.182-or-later browser context. A specific PACS, RIS, EHR, interface version, and current commercial deployment topology are not established.
Ever Fortune.AI's investor information-security policy page states an implemented information security management system covering confidentiality, integrity, and availability, with security training and measurement targets; the page states the company has completed ISO 27001 certification and holds ISO/IEC 27701 PII-processor certification after independent third-party audit. The company's certification-milestones page lists ISO/IEC 27001:2022, ISO 22301:2019, ISO/IEC 27018:2019, and ISO/IEC 27017:2015.
Vendor-wide
Checked 2026-10-27
Vendor statement; certificates were not read. Applicant name variants (including uppercase and punctuation variants of Ever Fortune.AI Co., Ltd.) are bridged via the vendor's EFAI product naming and the owning domain everfortuneai.com.tw. Exact-release scope is not established.
ACR AI Central provides an exact-submission model card for EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K212624 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.
Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.